Cis association of Ly49A with MHC class I restricts natural killer cell inhibition

Nature Immunology

Volumn 5, Issue 3, 2004, Pages 328-336

  Doucey, Marie Agnès ^a   Scarpellino, Léonardo ^a   Zimmer, Jacques ^a   Guillaume, Philippe ^a   Luescher, Immanuel F ^a   Bron, Claude ^a   Held, Werner ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; LIGAND; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; LECTIN; LY 49 ANTIGEN; LY ANTIGEN; LY-49 ANTIGEN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL INTERACTION; CONTROLLED STUDY; HOST CELL; IMMUNOREGULATION; INHIBITION KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; TARGET CELL; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; CYTOTOXICITY; CYTOTOXICITY TEST; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MOSAICISM; NEOPLASM; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, LY; BINDING SITES; CELL LINE; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MOSAICISM; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; TRANSFECTION;

EID: 1542287259     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1043     Document Type: Article

References (48)

1. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
2. Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99, 8826-8831 (2002).
3. Ljunggren, H.G. & Kärre, K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237-244 (1990).
4. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
5. + IL-2 activated natural killer cells. Nature 358, 66-70 (1992).
6. Kärre, K. NK cells, MHC class I molecules and missing self. Scand. J. Immunol. 55, 221-228 (2002).
7. Colucci, F., DiSanto, J.P. & Leibson, P. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3, 807-813 (2002).
8. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
9. Diefenbach, A., Jamieson, A.N., Liu, S., Shastri, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1, 95-97 (2000).
10. Diefenbach, A. & Raulet, D.H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181, 170-184 (2001).
11. Kane, K. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179, 1011-1015 (1994).
12. Hanke, T. et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11, 67-77 (1999).
13. Matsumoto, N., Ribaudo, R.K., Abastado, J.P., Margulies, D.H. & Yokoyama, W.M. The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand. Immunity 8, 245-254 (1998).
14. + NK cells after amino acid substitutions in the antigen binding cleft. Eur. J. Immunol. 28, 2872-2881 (1998).
15. Matsumoto, N., Mitsuki, M., Tajima, K., Yokoyama, W.M. & Yamamoto, K. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 193, 147-157 (2001).
16. Wang, J. et al. Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. J. Biol. Chem. 277, 1433-1442 (2002).
17. Karlhofer, F.M., Hunziker, R., Reichlin, A., Margulies, D.H. & Yokoyama, W.M. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J. Immunol. 153, 2407-2416 (1994).
18. Olsson, M. Y., Karre, K. & Sentman, C.L. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA 92, 1649-1653 (1995).
19. Held, W., Dorfman, J.R., Wu, M.-F. & Raulet, D.H. Major histocompatibility complex class I dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26, 2286-2292 (1996).
20. Kase, A., Johansson, M.H., Olsson-Alheim, M.Y., Kärre, K. & Höglund, P. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. J. Immunol. 161, 6133-6138 (1998).
21. Sjöström, A. et al. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. J. Exp. Med. 194, 1519-1530 (2001).
22. + natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function. J. Exp. Med. 194, 1531-1539 (2001).
23. low NK cells. J. Immunol. 159, 3189-3194 (1997).
24. Held, W., Cado, D. & Raulet, D.H. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 184, 2037-2041 (1996).
25. d transgene expression: evidence for partial missing-self recognition by Ly49A NK cells. J. Immunol. 167, 6256-6262 (2001).
26. Johansson, M.H., Bleberich, C., Jay, G., Kärre, K. & Höglund, P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I molecules. J. Exp. Med. 186, 353-364 (1997).
27. Michaelsson, J., Achour, A., Rölle, A. & Kärre, K. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the b2-microglobulin subunit. J. Immunol. 166, 7327-7334 (2001).
28. Held, W. & Raulet, D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 185, 2079-2088 (1997).
29. Dorfman, J.R. & Raulet, D.H. Major histocompatibility complex genes determine natural killer cell tolerance. Eur. J. Immunol. 26, 151-155 (1996).
30. Moody, A.M. et al. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 107, 501-512 (2001).
31. Daniels, M.A. et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glyosylation. Immunity 15, 1051-1061 (2001).
32. Storkus, W.J., Zeh III, H.J., Salter, R.D. & Lotze, M.T. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14, 94-103 (1993).
33. Tormo, J., Natarajan, K., Margulies, D. H. & Mariuzza, R. A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402, 623-631 (1999).
34. O'Callaghan, C.A., Cerwenka, A., Willcox, B. E., Lanier, L.L. & Bjorkman, P.J. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity 15, 201-211 (2001).
35. Sentman, C.L., Olsson, M.Y. & Kärre, K. Missing self recognition by natural killer cells in MHC class I transgenic mice: a "receptor calibration model" for how effector cells adapt to self. Semin. Immunol. 7, 109-119 (1995).
36. Höglund, P. et al. Host MHC class I gene control of NK cell specificity in the mouse. Immunol. Rev. 155, 11-28 (1997).
37. Matsumoto, N., Tajima, K., Mitsuki, M. & Yamamoto, K. H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetramer. Int. Immunol. 13, 615-623 (2001).
38. Shimaoka, M. & Springer, T.A. Therapeutic antagonists and conformational regulation of intergrin function. Nat. Rev. Drug Discov. 2, 703-716 (2003).
39. Lowin-Kropf, B. & Held, W. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J. Immunol. 165, 91-95 (2000).
40. Sykes, M. et al. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J. Exp. Med. 178, 223-229 (1993).
41. Wu, M.-F. & Raulet, D.H. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J. Immunol. 158, 1628-1633 (1997).
42. Labelle, J.L. & Truitt, R.L. Characterisation of a murine NKT cell tumor previously described as an acute myelogenous leukemia. Leuk. Lymphoma 43, 1637-1644 (2002).
43. + cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 89, 11381-1135 (1992 ).
44. Lowin-Kropf, B., Kunz, B., Schneider, P. & Held, W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32, 773-782 (2002).
45. Wilson, C.S., Moser, J.M., Altman, J.D., Jensen, P.E. & Lukacher, A.E. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL. J. Immunol. 162, 3933-3941 (1999).
46. Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
47. Storkus, W.J., Zeh, H.d., Maeurer, M.J., Salter, R.D. & Lotze, M.T. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J. Immunol. 151, 3719-27 (1993).
48. Kvist, S., Osterberg, L. & Peterson, P.A. Reactions and crossreactions of a rabbit anti-H2 antigen serum. Scand. J. Immunol. 7, 265-276 (1978).